The Lancet

Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial

dDepartment of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China eDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical ...
gadgets360

Lenovo Idea Tab Plus vs Alcatel OneTouch Pixi 3 (8) 3G comparison

Dimensions (mm) 278.80 x 181.05 x 6.29 209.00 x 124.50 x 9.20 ...
EurekAlert!

The Lancet: People with obesity at 70% higher risk of serious infection with one in ten infectious disease deaths globally potentially linked to obesity, study suggests

Study of over 540,000 people suggests people with obesity are 70% more likely to be hospitalised or die from an infectious disease; people with the most severe obesity face three times the risk.
The Lancet

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer ...

uDepartment of Biostatistics, Bristol Myers Squibb, Princeton, NJ, USA vGlobal Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA wDepartment of Translational Medicine, Bristol ...